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Abstract
Gammaherpesviruses establish lifelong latent infection in B lymphocytes and are the causative agent of several B- cell malig-
nancies and lymphoproliferative disorders. While a quiescent latent infection allows these pathogens to evade immune detec-
tion, initiation of an alternative lifecycle stage, known as lytic replication, is an essential step in the production and dissemination 
of infectious progeny. Although cessation of cellular proliferation is an eventual consequence of lytic induction, exactly how 
gammaherpesviruses manipulate the cell cycle prior to amplification of viral DNA remains under debate. Here we show that 
the onset of Kaposi's sarcoma- associated herpesvirus (KSHV) lytic reactivation in B cells leads to S- phase accumulation and 
that exit from G1 is required for efficient viral DNA replication. We also show that lytic replication leads to an S- phase- specific 
activation of the DNA damage response (DDR) that is abrogated when lytic replication is restricted to G0/G1. Finally, we observe 
that expression of early lytic viral genes results in cellular replication stress with increased stalling of DNA replication forks. 
Overall, we demonstrate that S- phase entry is important for optimal KSHV replication, that G1 arresting compounds are effec-
tive inhibitors of viral propagation, and that lytic- induced cell- cycle arrest could occur through the obstruction of cellular repli-
cation forks and subsequent activation of the DDR.
InTRoduCTIon
Gammaherpesviruses are double- stranded DNA viruses 
that infect and persist in B lymphocytes and can induce 
their proliferation and transformation. Kaposi's sarcoma- 
associated herpesvirus (KSHV) is a member of the 
Gammaherpesvirinae family that is responsible for the 
lymphoproliferative diseases multicentric Castleman’s 
disease (MCD) and primary effusion lymphoma (PEL) 
[1, 2]. KSHV, like other herpesviruses, has two distinct 
lifecycle stages known as latent infection and lytic replica-
tion. Latency is established following nuclear entry and is 
characterized by translation of only a limited number of 
viral proteins that aid maintenance of extrachromosomal 
viral episomes while promoting host- cell survival and cell- 
cycle progression. Although the quiescent latency phase is 
advantageous for evading host- cell immune surveillance 
and establishing lifelong persistence, viral dissemina-
tion requires rapid amplification of viral genomes and 
assembly of infectious virions. To this end, herpesviruses 
sporadically execute a lytic replication phase that involves 
expression of the full repertoire of viral genes. Viral genes 
expressed specifically in the lytic phase have been grouped 
into immediate- early genes (expressed first and required 
for expression of other lytic genes), early genes (including 
those that encode viral replication proteins) and late genes 
(includes those that encode structural proteins required for 
virion assembly). Viral episomes are duplicated in globular 
domains in the nucleus known as replication compartments 
(RCs) and the concluding stages of productive lytic replica-
tion involve lysis of the host cell permitting rapid egress of 
infectious progeny.
DNA viruses must manipulate the host- cell cycle in order to 
promote efficient replication of their genetic material. Small 
DNA viruses, such as papillomaviruses and adenoviruses, 
rely on the host replication machinery for viral genome 
replication and consequently facilitate S- phase entry before 
viral DNA amplification proceeds. During latent infection, 
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KSHV DNA is also replicated by host polymerases during 
S phase and these duplicated episomes are then segregated 
to daughter cells along with cellular DNA during mitosis. 
The situation regarding cell- cycle manipulation during lytic 
replication of gammaherpesviruses is less well- defined. As 
these pathogens encode their own replisome components, 
they are, in theory, less dependent on host replication 
resources for their successful propagation. Although the 
transition to the lytic replication phase will inevitably lead 
to cessation of the cell cycle, since cellular DNA replication 
is halted and cell lysis eventually occurs, there have been 
conflicting reports regarding the cell- cycle phase in which 
productive lytic replication takes place. Earlier reports indi-
cated that lytic cycle initiation leads to an accumulation 
of cells in G1 [3, 4]. The proposed rationale was that, by 
restricting S- phase entry, the virus avoids competition with 
cellular DNA for replication resources. In support of these 
findings, both the KSHV immediate- early proteins RTA and 
K8α have been shown to negatively regulate the G1/S transi-
tion when expressed alone [4, 5]. In contrast, another study 
presented evidence that S phase provides a more conducive 
environment for KSHV replication due to upregulation of 
genes that promote DNA replication, cell survival and lipid 
metabolism [6]. More recently, the G2/M checkpoint has 
also been implicated as a target during KSHV lytic replica-
tion [7]. The authors showed that iSLK.219 cells, containing 
recombinant KSHV, bypass the G1/S checkpoint following 
lytic induction but accumulate in G2/M via stimulation of 
the p53- p21 signalling axis.
We, and others, have previously reported that KSHV lytic 
replication results in cellular DNA damage and concurrent 
activation of the DNA damage response (DDR) [8–11]. As 
part of our previous report into the effect of DDR kinase 
inhibitors on KSHV replication efficiency, we observed, 
through examining relative DNA content, that inducing 
KSHV lytic replication in a PEL line increased the propor-
tion of these cells in S phase [10]. We also observed that 
the reduction in replication efficiency detected following 
ATR inhibition was also accompanied by an increase in 
the number of G1 arrested cells. Furthermore, one of the 
DDR- related signalling events that occurred in these cells 
during lytic replication was phosphorylation of RPA32 on 
serines 4 and 8. This phosphorylation event is associated 
with homologous recombination- dependent DNA end 
resection that occurs in S and G2 phases of the cell cycle 
suggesting that the DDR elicited during the lytic phase may 
occur outside of G1.
In this report, we have closely examined the cell- cycle 
changes that take place in B cells containing lytically 
replicating KSHV and assessed the importance of these 
manipulations for viral replication efficiency. Using several 
well- established indicators of cell- cycle phase distribution, 
we demonstrate here that lytic replication of KSHV in the 
BCBL-1 PEL cell line leads to S- phase accumulation. In 
addition, we show that imposing a G1 block in these cells 
prior to lytic induction results in significantly reduced viral 
replication efficiency. Finally, we show that expression of 
early viral genes results in cellular DNA replication stress 
and S- phase- specific activation of the DDR, which is abro-
gated when lytic replication is limited to the G0/G1 phase. 
Overall, we demonstrate that host transition through the 
G1/S- phase checkpoint is an important aspect of the KSHV 
lytic replication strategy and that chemical inhibition of 
S- phase entry is an effective means of restricting herpes-
virus propagation.
RESuLTS
Reactivation of KSHV in PEL cells leads to S-phase 
accumulation
BCBL-1 is a PEL cell line derived from a post- germinal 
centre B- cell population that contains multiple copies of 
the KSHV episome [12]. TREx BCBL-1- RTA cells have 
been modified to express the lytic switch protein RTA 
from a doxycycline- inducible promotor [13]. Initially, we 
wanted to confirm that KSHV lytic replication in B cells 
leads to cell- cycle arrest in S phase. We therefore employed 
propidium iodide (PI) staining combined with flow cytom-
etry, a well- characterized cell- cycle assay based on relative 
DNA content, in order to assess what cell- cycle changes 
take place following induction of lytic replication (Fig. 1a). 
Experiments were performed using the inhibitor of viral 
DNA synthesis phosphonoacetic acid (PAA) in order to 
ensure that viral DNA was not detected as cellular DNA 
leading to overrepresentation of S- phase cells [14]. TREx 
BCBL-1- RTA cells were treated with PAA alone or PAA in 
combination with doxycycline and harvested at 6 h intervals 
up until 24 h. Cell- cycle profiles of cells containing lytic 
KSHV were compared with uninduced controls at the same 
time points. Treatment with PAA alone did not result in 
any notable cell- cycle changes in these cells after 24 h. In 
contrast, treatment with doxycycline and PAA led to a 
notable increase in the number of cells in S phase after 24 h 
with a corresponding reduction in the number of cells in 
G0/G1 and G2/M.
In cells containing lytic virus, KSHV RCs can be visualised 
with immunofluorescence microscopy (IF) using an antibody 
against the viral single- stranded DNA binding protein (SSB) 
[15]. To confirm that cells containing lytic KSHV enter S phase, 
we monitored levels of the cell- cycle marker protein mitosin, 
to determine at what phase of the cell cycle KSHV RCs form. 
Mitosin is a kinetochore- associating protein that accumulates 
gradually as cells progress through S phase and is expressed 
maximally in G2 and M phases before being degraded following 
the completion of mitosis [16]. Mitosin is a commonly used cell- 
cycle marker employed in IF as cells with bright nuclear mitosin 
staining are known to be in the G2 phase, mitosin- negative cells 
represent those in G1, while S- phase cells contain intermediate 
levels of this protein. Mitosin levels during formation of KSHV 
RCs were examined by IF in TREx BCBL-1- RTA cells treated 
with doxycycline for 24 h(Fig. 1b, c). Images of cells with mitosin 
staining typical of G2 and G1 cells that were negative for lytic 
KSHV are included for comparison (Fig. 1b). We observed 
that cells containing KSHV RCs displayed mitosin staining 
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Fig. 1. Reactivation of KSHV in PEL cells leads to S- phase accumulation. (a) Cell- cycle profiles of TREx BCBL-1- RTA cells treated with 
either PAA or PAA and doxycycline for the indicated times. Percentages of cell- cycle phase distribution represent the average of three 
independent experiments. (b) Nuclear expression of mitosin following lytic reactivation of KSHV in TREx BCBL-1- RTA cells. Included are 
representative images of mitosin levels in G1 and G2 as well as images of cells containing viral RCs marked by the viral SSB protein. 
(c) Relative mitosin intensities corrected for background in asynchronous control cells and dox- treated KSHV RC- positive cells. (d) 
Western- blot analysis of cyclin proteins and phospho H3 levels during the KSHV lytic replication cycle after doxycycline treatment of 
BCBL-1 and TREx BCBL-1- RTA cells. Expression of viral K8α and SSB confirm induction of lytic reactivation. (e) Densitometry analysis 
of relative levels of cyclins A, B1 and E in TREx BCBL-1- RTA cells following addition of doxycycline. Data points represent the average of 
three repeat experiments. Values were calculated relative to β-Actin intensity and expressed as a ratio of un- reactivated control cells. 
Error bars represent the standard error of the mean (sem).
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that was intermediate between that of G1 and G2 cells indi-
cating that KSHV RCs form in S phase. Images of multiple cells 
containing viral RCs of differing sizes were taken to represent 
progressive stages of viral DNA amplification (Fig. 1b). Relative 
mitosin intensities in both asynchronous uninduced cells and 
in dox- treated viral RC- positive cells were also calculated and 
compared using a distribution dot plot (Fig. 1c). The cell- cycle 
distribution of uninduced TREx BCBL-1- RTA cells determined 
by PI staining was used to indicate the range of mitosin inten-
sity values that corresponded to each cell- cycle phase. This 
analysis clearly illustrates that cells containing lytic KSHV have 
a narrower distribution of mitosin intensities compared with 
control cells. It was also determined that 76 % of all RC- positive 
cells measured had a mitosin intensity value that lies within the 
range that corresponds to S phase in control cells (Fig. 1c).
As an additional indicator of cell- cycle distribution during 
lytic replication, Western blotting was used to monitor levels 
of cell- cycle marker proteins following doxycycline treatment 
of control BCBL-1 cells and TREx BCBL-1- RTA cells (Fig. 1d). 
Blotting for the KSHV lytic proteins K8α and SSB was used to 
verify induction of viral replication in TREx BCBL-1- RTA cells. 
To confirm that cells containing lytic virus do not enter mitosis, 
levels of phosphorylated H3 at serine 10 were also examined. 
Levels of this mitotic marker were clearly reduced 18 h after 
lytic induction compared with uninduced controls indicating 
that lytic replication does not lead to mitotic accumulation 
(Fig. 1d). Next, levels of cyclin A, B1 and E were examined at 
the same time points (Fig. 1d, e). Cyclins are a group of proteins 
that regulate cell- cycle progression through interactions with 
cyclin- dependent kinases (CDKs) and whose expression varies 
throughout the cell cycle [17]. Expression of cyclin A increases 
during S phase and is maximal at the end of G2, cyclin B1 levels 
peak at the G2/M boundary, while cyclin E levels are maximal 
during the G1 to S- phase transition. Levels of both cyclin B1 and 
cyclin E were notably reduced following doxycycline treatment 
indicating that viral reactivation does not lead to an accumula-
tion of cells at the G1/S or G2/M boundaries. Levels of cyclin 
A remained relatively stable but appeared slightly reduced by 
24 h. Since cyclin A levels are low at the start of S phase and 
accumulate gradually until G2, a slight reduction in this cyclin 
during the lytic cycle could be due to cells arresting in early to 
mid- S phase. Western blots of these three cyclin proteins were 
also quantified relative to β-Actin across three repeat experi-
ments using densitometry (Fig. 1e). This analysis clearly shows a 
consistent reduction in cyclins B1 and E during lytic replication 
in contrast to the relatively steady levels of cyclin A. Overall, 
these findings demonstrate that induction of lytic replication in 
BCBL-1 cells leads to cell- cycle arrest in S phase where forma-
tion and expansion of viral RCs takes place.
Restricting S-phase entry in PEL cells using serum 
depletion attenuates KSHV replication and ddR 
activation following lytic induction
Having determined that lytic replication leads to S- phase 
accumulation in B cells, we next wanted to assess whether 
restriction of S- phase entry has a negative effect on viral repli-
cation efficiency. We initially used serum depletion to induce 
a G0/G1 block in TREx BCBL-1- RTA cells prior to viral 
reactivation. By varying depletion times and serum levels, we 
found that reducing the serum concentration to 0.5 % for 72 h 
resulted in between 80 and 90 % of cells restricted to the G0/
G1 phase and only a minimal increase in the sub- G1 fraction 
(<1.5 %) representing apoptotic cells (Fig. 2a).
In order to test the effect of serum depletion on KSHV lytic 
replication, TREx BCBL-1- RTA cells were cultured with 10 % 
or 0.5 % serum for 72 h before the addition of doxycycline. In 
addition, a third population of cells were cultured in 0.5 % 
serum for 72 h before being supplemented with 10 % serum 
2 h prior to doxycycline treatment (see schematic Fig. 2a). 
Initially, cells were harvested after 24 h and cell- cycle profiles 
were compared with uninduced cells (Fig. 2b). In the absence 
of doxycycline, the cells depleted of serum for 96 h had 
predominantly accumulated in G0/G1 with 5.6 % in S phase 
on average compared with a mean of 29 % in the cells with 
normal serum levels. Cells with serum restored 72 h after 
serum depletion did not appear to be synchronized 24 h later 
and the G0/G1 fraction remained elevated compared with 
control cells. This condition was included here as it provides 
a control for lytic replication in the presence of normal serum 
levels but with restricted exit from G0/G1. Following addition 
of doxycycline to asynchronous cells, there was an increase in 
the S- phase fraction and a reduction in the G0/G1 and G2/M 
fractions as previously shown. In contrast, serum- depleted 
cells treated with doxycycline remained primarily in G0/G1 
with an accompanying increase in the sub- G1 fraction indi-
cating elevated cell death. Restoration of serum prior to lytic 
induction resulted in more than twice the proportion of cells 
in S phase compared with serum depleted cells although the 
majority were still in G0/G1 and the sub- G1 fraction was also 
elevated compared with the asynchronous controls.
Western blotting was also used to determine whether 
expression of lytic viral genes was affected by serum deple-
tion (Fig. 2c). Levels of cyclin A and E were also monitored 
to confirm the restriction of S- phase entry. Levels of the 
immediate early protein K8α and the early viral SSB protein 
were unaffected by these culture conditions although levels 
of the late K8.1A, which is expressed after amplification of 
viral DNA, were clearly reduced following serum depletion. 
In addition, activation of the DDR following lytic induction 
was also assessed by blotting for levels of phosphorylated 
NBS1, RPA32 and H2AX (Fig. 2d). Restriction of S- phase 
entry resulted in a reduction in phosphorylation of RPA32 at 
serines 4 and 8 and NBS1 at serine 343 although the level of 
phosphorylated H2AX remained elevated.
To determine if these culture conditions resulted in reduced 
viral replication efficiency, relative viral genome load was 
determined by qPCR 48 h following doxycycline treatment 
(Fig. 2e). In serum- depleted cells there was a sharp reduc-
tion in viral genome amplification, which was only partially 
rescued in the serum- restoration conditions. The relative 
reduction in viral DNA replication efficiency in these culture 
conditions was approximately proportional to the fraction of 
cells entering S phase 24 h following doxycycline treatment. 
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Fig. 2. Restricting S- phase entry in PEL cells using serum depletion attenuates KSHV replication and DDR activation following lytic 
induction. (a) Representative cell- cycle distribution of TREx BCBL-1- RTA cells following 72 h culture in either 10 % or 0.5 % serum. 
(b) Representative cell- cycle profiles 24 h following doxycycline treatment in TREx BCBL-1- RTA cells cultured in normal serum (10 % 
FCS), serum depleted (0.5 % FCS) or serum- replenished conditions (0.5 % FCS followed by 10 % FCS). Percentages of cell- cycle phase 
distribution represent the average of three independent experiments. (c, d) Western- blot analysis of induced TREx BCBL-1- RTA cells 
cultured in the above serum concentrations measuring levels of (c) cyclins A and E and lytic proteins K8α, SSB and K8.1A as well as 
(d) total and phosphorylated DDR proteins NBS1, RPA32 and H2AX. (e, f) Lytic replication efficiency in induced TREx BCBL-1- RTA cells 
cultured in the above serum concentrations measured by (e) qPCR analysis of relative genome load 48 h after lytic induction and (f) IF 
quantification of release of infection virus 24 and 48 h following doxycycline treatment. Statistical analyses were performed using a two- 
tailed and unpaired Student t- test, *, P<0.05; **, P<0.01; ***, P<0.001. Error bars represent the sem.
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Production of infectious virus following serum depletion after 
both 24 and 48 h was also determined by treating EA.hy926 
cells with supernatants from induced TREx BCBL-1- RTA 
cells and quantifying the number of infected cells by immu-
nofluorescence staining for the latent KSHV protein LANA 
(Fig. 2f). There was a similar reduction in infectious virus 
production in both serum- depleted conditions after both 
24 and 48 h confirming the attenuation of viral replication 
following restricted S- phase entry. Overall, these results 
indicate that S- phase entry is required for proficient KSHV 
replication and activation of specific aspects of the DDR 
during the lytic cycle.
Treatment of PEL cells with the CdK4/6 inhibitor 
palbociclib results in G1 accumulation and reduced 
viral replication efficiency
To confirm that restriction of S- phase entry has a negative 
effect on viral replication, we next employed a reversible 
small- molecule inhibitor of CDK4/6 known as palbociclib 
that induces a G1 phase arrest in proliferating cells [18, 19]. 
In the absence of doxycycline, addition of 1 µM palbociclib to 
TREx BCBL-1- RTA cells caused over 95 % to accumulate in 
G0/G1 after 24 h (Fig. 3a). Induction of lytic replication using 
doxycycline 1 h following palbociclib treatment resulted in 
an average of less than 3 % of cells entering S phase after 24 h 
compared with an average of 47 % in cells treated with DMSO. 
In addition, the presence of palbociclib during lytic replica-
tion did not lead to an increase in the proportion of cells in 
the sub- G1 fraction that typically represents apoptotic cells.
Having established that this compound restricts S- phase entry 
during lytic replication in TREx BCBL-1- RTA cells, we next 
examined palbociclib- induced changes in lytic gene expres-
sion and DDR activation by Western blotting (Fig. 3b, c). As 
before, expression of cyclin A and E was used to confirm G1 
accumulation following palbociclib treatment while levels 
of the immediate- early K8α, early SSB and late K8.1A viral 
proteins were examined to evaluate lytic gene expression 
in G1 (Fig. 3b). Following doxycycline treatment, levels of 
immediate early K8α and early SSB were actually elevated in 
G1 arrested cells but expression of late K8.1A was severely 
attenuated compared with the DMSO control suggesting 
restricted amplification of viral DNA. It was also notable that, 
in the absence of doxycycline, CDK4/6 inhibition resulted in 
increased levels of immediate early K8α and early SSB but not 
late K8.1A. This suggests that this compound alone promotes 
initiation of the early lytic gene cascade but that this does not 
progress as far as expression of late viral genes. Similarly to 
the observation in serum- depleted cells, inhibition of S- phase 
entry with palbociclib during KSHV lytic replication ablated 
phosphorylation of the DDR substrates NBS1 and RPA32 
(Fig. 3c). As also seen in serum- depleted cells, levels of phos-
phorylated H2AX were not reduced in G1- arrested cells but 
were in fact elevated after 48 h.
Next, we wanted to confirm that palbociclib had a negative 
effect on KSHV lytic replication efficiency as indicated by the 
reduction in levels of K8.1A following G1 arrest. Multiplication 
of viral genomes was first measured by qPCR and calculated 
relative to latently infected cells (Fig. 3d). Inhibition of CDK4/6 
drastically reduced viral genome load 48 h after initiation 
of lytic replication compared with vehicle- treated controls. 
As before, infectious virus release was also determined my 
measuring infectivity of viral supernatants following infection 
of endothelial cells (Fig. 3e). Treatment with palbociclib prior 
to doxycycline resulted in a reduction in the release of infec-
tious virus after 24 and 48 h compared with DMSO- treated 
controls. Treatment with palbociclib alone did not increase the 
percentage of infected cells compared with uninduced, DMSO- 
treated controls. Similar to the findings using serum depletion, 
these results confirm that restriction of S- phase entry in PEL 
cells restricts KSHV replication and attenuates activation of the 
DDR following initiation of the lytic programme.
Expression of early lytic genes leads to increased 
cellular dnA fork stalling
Activation of the DDR in S phase can be the result of DNA 
replication stress, defined as any event that interferes with the 
progress of the DNA replication machinery. To see if S- phase 
arrest and DDR activation during KSHV lytic replication is 
accompanied by DNA replication stress, we employed the DNA 
fibre assay to determine the relative occurrence of replication 
fork stalling in cells containing lytic KSHV. This assay involves 
sequential labelling of DNA with two thymidine analogues, 
chloro- deoxyuridine (CldU) and iodo- deoxyuridine (IdU), that 
are fluorescently labelled following spreading of the DNA on 
glass slides. The DNA structures generated can then be imaged 
and quantified as ongoing replication forks, containing both 
CldU and IdU, or forks that have stalled in the first label and 
therefore contain only CldU. While it is possible that replica-
tion forks will stall in the second label leading to shorter IdU 
tracts compared with CldU, shorter IdU tracts could also be the 
result of slowing of replication and are therefore not classified 
as stalled forks here.
TREx BCBL-1- RTA cells were treated with doxycycline for 10 h 
before being pulse labelled with the nucleoside analogues CldU 
and IdU for 20 mins each (Fig. 4). Replication was analysed at 
10 h after doxycycline treatment as this is sufficient time for 
expression of immediate- early and early viral genes but prior 
to amplification of viral genomes, which minimizes the possi-
bility of assaying viral, rather than cellular, DNA [20]. This DNA 
fibre analysis revealed that induction of lytic replication resulted 
in a significant decrease in the percentage of ongoing replica-
tion forks (CldU+IdU), and an accompanying increase in the 
proportion of stalled replication forks (CldU only) compared 
with latently infected PEL cells. This observation indicates that 
early lytic gene expression leads to cellular DNA replication 
stress, which impedes replication fork progression.
dISCuSSIon
Here we have shown that S- phase entry occurs following 
expression of KSHV lytic genes and is a prerequisite for 
optimal viral replication in PEL cells. We cannot rule out 
that viral proteins have a direct regulatory effect on some 
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Fig. 3. Treatment of PEL cells with the CDK4/6 inhibitor palbociclib results in G1 accumulation and reduced viral replication efficiency. (a) 
Representative cell- cycle profiles of TREx BCBL-1- RTA cells treated with either DMSO or palbociclib for 1 h followed by doxycycline for 
24 h. Percentages of cell- cycle phase distribution represent the average of three independent experiments. (b, c) Western- blot analysis 
of induced TREx BCBL-1- RTA cells treated with either palbociclib or DMSO measuring levels of (b) cyclins A and E and lytic proteins K8α, 
SSB and K8.1A as well as (c) total and phosphorylated DDR proteins NBS1, RPA32 and H2AX. (d, e) Lytic replication efficiency in induced 
TREx BCBL-1- RTA cells treated with either palbociclib or DMSO measured by (d) qPCR analysis of relative genome load 48 h after lytic 
induction and (e) IF quantification of release of infection virus 24 and 48 h following doxycycline treatment. Statistical analyses were 
performed using a two- tailed and unpaired Student t- test, **, P<0.01; ***, P<0.001. Error bars represent the sem.
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of the host cell cycle proteins examined here. However, a 
higher DNA content in the absence of viral replication, posi-
tive staining for mitosin and reduced levels of cyclin E all 
indicate that B cells containing lytic KSHV do not accumu-
late in G1 or at the G1/S transition. These findings are in 
contrast to earlier reports proposing that avoidance of S- phase 
entry is a specific replication strategy employed by several 
herpesviruses including KSHV, Epstein- Barr virus (EBV) 
and herpes simplex virus 1 (HSV-1) [4, 21, 22]. However, 
in support of our finding that KSHV lytic replication occurs 
in S phase, a previous study using EBV- infected epithelial 
cells has demonstrated that the replication factories of this 
closely related gammaherpesvirus also form outside of G1 
[23]. Using a Cdt1- eGFP fusion protein to track cell- cycle 
progression in live cells containing lytic virus, the authors 
observed that EBV RCs develop in early S phase and sequester 
the PCNA DNA clamp while excluding cellular DNA and 
histones. Previous studies demonstrating that individual 
expression of the KSHV lytic proteins RTA and K8α results 
in G1 arrest have provided additional evidence that preven-
tion of S- phase entry is an advantageous herpesvirus adapta-
tion [4, 5]. However, it is also known that V- cyclin, a KSHV 
d- type cyclin homologue expressed in both the latent and 
lytic phases, inactivates p27 promoting cell- cycle progres-
sion through G1 into S phase [24]. The phosphorylation of 
retinoblastoma protein (RB) by herpesvirus- encoded kinases 
has also been demonstrated to promote transit through the 
G1/S transition [25]. Overall, while potentially informative, 
cell- cycle manipulations observed following expression of 
individual viral genes should be considered in the context of 
the wider lytic expression cascade.
To examine the importance of S- phase entry for efficient viral 
replication we artificially imposed a G0/G1 block prior to 
lytic reactivation. There are several commonly used methods 
of inducing cell- cycle arrest in cultured cells. However, we 
wanted to avoid compounds that directly interfere with DNA 
replication or that induce high levels of cell death in the 
absence of lytic induction. Serum depletion is a commonly 
used method for synchronizing cells prior to S- phase entry 
and effectively inhibited replication of viral genomes in this 
study. However, serum withdrawal negatively impacts cellular 
transcription, protein production and lipid- biosynthesis 
pathways which the virus may rely on to successfully execute 
the lytic programme. Consequently, to confirm that cells in 
G0/G1 do not support efficient viral replication, we turned 
to the CDK4/6 inhibitor palbociclib. This compound exerts 
anti- proliferative effects on phospho RB- positive tumour 
cells and has shown promise in treatment of advanced breast 
cancer [26]. In this investigation, CDK4/6 inhibition robustly 
restricted viral replication efficiency but also appeared to 
induce early lytic gene expression in the absence of doxycy-
cline treatment. Despite this, it appears that cells treated with 
palbociclib alone do not support complete lytic replication 
of KSHV and display increased phosphorylation of H2AX 
indicating DNA damage. If this early lytic gene expression 
and DDR activation leads to increased cell death compared 
with uninfected cells then CDK4/6 inhibition could be a 
Fig. 4. Expression of early lytic genes leads to increased cellular DNA fork stalling. DNA fibre analysis of ongoing and stalled replication 
forks in TREx BCBL-1- RTA cells treated with doxycycline for 10 h. Cells were pulsed with CldU for 20 mins followed by IdU for 20 mins before 
DNA spreading and immunofluorescence staining. A minimum of 500 DNA fibres were analysed for each of three repeat experiments. 
Statistical analyses were performed using a two- tailed and unpaired Student t- test, *P<0.05; **, P<0.01. Error bars represent the sem.
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promising option as a targeted anti- viral agent. The potential 
of palbociclib to treat this aggressive B- cell lymphoma has 
been highlighted recently following the results of a screen 
examining drug- susceptible targets in PEL cells [27]. While 
the authors did not examine the lytic replication phase of 
KSHV, they did observe a robust G1 arrest in latently infected 
PEL cells as is presented here.
We have also demonstrated that phosphorylation of RPA32 
and NBS1 following early viral gene expression is dependent 
on exit from G1. Previous experiments using ganciclovir, an 
inhibitor of viral DNA replication, showed that abrogation of 
late gene expression or viral genome amplification does not 
inhibit phosphorylation of RPA32 in PEL cells [10]. Together, 
these findings indicate that early lytic gene expression 
following KSHV reactivation specifically activates the DDR 
in S phase. Despite the impaired phosphorylation of DDR 
proteins following S- phase entry, we did not observe reduced 
phosphorylation of H2AX on serine 139 when lytic reactiva-
tion was limited to G1. Phosphorylated H2AX is a sensitive 
marker of DNA damage but can occur due to DNA fragmen-
tation during apoptotic cell death [28]. The c- Jun N- terminal 
kinase can phosphorylate H2AX during programmed cell 
death and we did observe increased indicators of apoptosis in 
serum- depleted cells treated with doxycycline. However, the 
same increase in apoptosis was not evident following palbo-
ciclib treatment that also induced elevated levels of H2AX 
phosphorylation. It appears that while some aspects of the 
DDR are activated specifically in S phase, lytic replication in 
G1- arrested cells still promotes the appearance of this DNA 
damage marker.
Finally, we demonstrate here that KSHV reactivation causes 
increased frequency of stalled DNA replication forks. This 
increase was detected prior to amplification of viral DNA or 
late gene expression indicating that early lytic gene expression 
is sufficient to induce cellular replication stress. It has long been 
known that host DNA replication is halted in favour of viral 
genome amplification during the lytic stage of the herpesvirus 
lifecycle. While cell- cycle cessation in G1 has previously been 
postulated as a viral strategy to prevent cellular DNA replica-
tion, it was recently shown that the KSHV protein encoded 
by ORF59 interacts with the minichromosome maintenance 
protein complex (MCM), restricting its access to chromatin 
and hindering progression of replication forks [29]. While the 
authors did not measure the progression of individual replica-
tion forks using the fibre assay, the increase in stalled forks we 
have observed here could be the result of ORF59 expression 
or the combined actions of several viral proteins. Replication 
stress can lead to various types of DNA damage including 
long stretches of single- stranded DNA following helicase/
polymerase uncoupling and one- sided DSBs following fork 
cleavage [30]. It is likely that viral- induced replication stress 
contributes to the S- phase- specific DDR activation observed 
after lytic induction and may also serve to halt cellular DNA 
replication and block cell- cycle progression to mitosis.
In summary, we have confirmed the importance of S- phase 
entry for productive KSHV lytic replication in B cells. 
Significantly, we have also demonstrated the effectiveness of 
the chemotherapeutic drug palbociclib against KSHV- infected 
B cells through both its restriction of cellular proliferation 
during latency and its deleterious effect on the production 
of infectious virions following lytic induction. Prognosis 
for patients with PEL remains poor with treatment options 
limited to standard chemotherapy regimens and relapse 
common after treatment [31]. The fact that lytic gene expres-
sion has been implicated in KSHV- mediated tumourigenesis, 
and is also required for dissemination of infectious virus in the 
tumour microenvironment [32], underlines the importance 
of understanding virus–host interactions that occur during 
this lifecycle phase. In turn, this will hopefully contribute to 
the development of new therapeutic approaches targeting 
aggressive virus- associated malignancies such as PEL.
METHodS
Cell culture
BCBL-1 cells were cultured in RPMI media (Gibco) supple-
mented with 10 % FBS (Sigma- Aldrich) and 1 % penicillin- 
streptomycin (Gibco), while TREx BCBL-1- RTA cells were 
cultured in the same media with the addition of 100 µg ml−1 of 
hygromycin B (Roche). Latent KSHV in TREx BCBL-1- RTA 
cells was reactivated by addition of 0.5 µg ml−1 doxycycline 
(Sigma Aldrich). EA.hy926 cells were cultured in DMEM 
(Sigma Aldrich) supplemented with 10 % FBS and 1 % 
penicillin- streptomycin. All cell lines were cultured at 37 °C, 
5 % CO2 in a humidified incubator. To induce cell- cycle arrest 
in G1, 1 µM palbociclib (PD-0332991) (Sigma Aldrich) was 
added to culture media.
PI staining
To analyse cell- cycle distribution, TREx BCLB-1- RTA cells 
were washed in PBS, fixed in 70 % ethanol and stored at 
−20 °C. Fixed cells were washed in PBS twice prior to addi-
tion of PBS containing 20 µg ml−1 RNase (Sigma Aldrich) and 
10 µg ml−1 propidium iodide (PI) solution (Sigma Aldrich). 
Relative DNA content was then analysed using an Accuri C6 
flow cytometer (BD) and FlowJo software (Tree Star). Inhibi-
tion of viral DNA replication was achieved by addition of 
100 µg ml−1 phosphonoacetic acid (PAA) (Sigma Aldrich) to 
culture media.
Western blots
Whole- cell extracts were prepared by suspension of cell 
pellets in UTB buffer (8 M urea, 50 mM Tris HCl pH 7.4, 
150 mM β-mercaptoethanol) followed by sonication on ice. 
Protein quantification was carried out using Bradford reagent 
(Bio- Rad), and appropriate volumes suspended in Laemmli 
sample buffer (Bio- Rad) before resolution of proteins using 
standard SDS- PAGE procedures.
The following primary antibodies were used for Western blot-
ting in this study: K8α/K- bZIP (Sigma Aldrich, SAB5300152), 
ORF6/SSB (provided by Professor Gary Hayward), K8.1A 
(provided by Professor David Blackbourn). Cyclin A (Santa 
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Cruz, sc-596), Cyclin E (Santa Cruz, sc-247), Cyclin B1 (Santa 
Cruz, sc-752), NBS1 (Genetex, GTX70222), phospho- NBS1 
(S343) (Abcam, ab47272), RPA32 (Calbiochem, NA19L), 
phospho- RPA32 (S4/S8) (Bethyl, A300- 245A), H2AX (Cell 
Signalling, 7631), γH2AX (S139) (Merck Millipore, 05–636), 
Histone H3 antibody (Abcam, ab18521), Phospho- Histone 
H3 (S10) (Cell Signalling, 9701), β-Actin (Sigma, A2228). 
Proteins were then detected using polyclonal Goat Anti- 
Mouse (Dako Laboratories, P0447) or polyclonal Swine Anti- 
Rabbit (Dako Laboratories, P0399) secondary antibodies 
conjugated to HRP. Proteins were detected using enhanced 
chemiluminescence (ECL) reagent (GE Healthcare) and 
autoradiography. Densitometry of cyclin blots was carried 
using ImageJ software (National Institutes of Health; http:// 
rsbweb. nih. gov/ ij/) with values normalized to a β-Actin 
loading control.
Immunofluorescence microscopy
BCBL-1 cells were cytospun onto glass slides, fixed in 4 % 
paraformaldehyde and permeabilized in 0.5 % Triton X-100 
(Sigma Aldrich). Cells were blocked in 10 % heat inactivated 
goat serum (HINGS) for 30 min followed by addition of 
primary antibodies diluted in 10 % HINGS for 1 h. Slides were 
washed three times in PBS followed by addition of anti- rabbit 
Alexa Fluor 594 and anti- mouse Alexa Fluor 488 conjugated 
secondary antibodies (Thermo Fisher Scientific) for 1 h. 
Following three washes in PBS, slides were counterstained 
with DAPI nuclear stain (Life Technologies) and coverslips 
mounted with Prolong Gold antifade reagent (Life Tech-
nologies). The following primary antibodies were used for 
immunofluorescence: ORF6/SSB (provided by Professor Gary 
Hayward), Mitosin (Abcam, ab90). Relative mitosin intensity 
corrected for background fluorescence was calculated using 
ImageJ software on 150 cells from each condition across three 
independent experiments.
Quantification of infectious virus production from TREx 
BCBL-1- RTA was carried out as previously described [11]. In 
brief, supernatants containing infectious KSHV were added 
to EA.hy926 cells grown on coverslips and spinoculated (330 
g, 20 min, room temperature). After 48 h, the percentage of 
infected cells was determined by immunofluorescence staining 
for LANA (Novacastra). For each independent experiment, 
a minimum of 500 cells were analysed and statistical analysis 
was performed using GraphPad Prism (GraphPad Software).
Quantitative PCR
Determination of relative viral load was carried out as previ-
ously described [11]. Briefly, genomic DNA was extracted 
from TREx BCBL-1- RTA cells using a Wizard genomic 
DNA purification kit (Promega) and amplification reactions 
were performed in an Applied Biosystems 7500 Fast Dx real- 
time PCR machine. Primers were used against the cellular 
β2- microglobulin (B2m) gene and the viral ORF47 gene. Viral 
load in induced cells was calculated as fold change relative to 
uninduced controls using the comparative threshold cycle 
(CT) method.
The following primer sequences were used B2m- Fwd (5′- 
GGAA TTGA TTTG GGAG AGCATC-3′) and B2m- Rev, 
(5′- CAGG TCCT GGCT CTAC AATT TACTAA-3′), and 
viral DNA; ORF47- Fwd (5′- CGCG GTCG TTCG AAGA 
TTGGG-3′) and ORF47- Rev (5′- CGAG TCTG ACTT CCGC 
TAACA-3′).
dnA fibre analysis
Sub- confluent TREx BCBL-1- RTA cells were treated with 
0.5 µg ml−1 doxycycline for 10 h before chloro- deoxyuridine 
(CldU) (Sigma Aldrich), at a final concentration of 25 µM, was 
added to cell- culture media for 20 mins. Cells were pelleted 
and washed in media containing 250 µM iodo- deoxyuridine 
(IdU) (Sigma Aldrich) before being re- suspended in media 
containing 250 µM IdU for a total exposure to IdU of 20 mins. 
Cells were pelleted and re- suspended in ice cold PBS at 
a concentration of 5×105 ml−1. 2 µl of cell suspension was 
placed on glass slides, mixed with 7 µl of spreading buffer 
(200 mM Tris- HCl, pH 7.5, 50 mM EDTA, 0.5 % SDS) and 
spread across the glass by tilting at an angle. Slides were air 
dried and fixed in 3 : 1 methanol, acetic acid for 10 mins. For 
immunostaining of DNA fibres, DNA was denatured using 
2.5 M HCL for 1 h, washed in PBS and submerged in blocking 
solution (1 % BSA, 1 % Tween 20 in PBS) for 30 mins. DNA 
immunostaining was carried out by submersion in rat anti- 
BrdU (clone BU1/75, ICR1; Abcam, ab6326), and mouse 
anti- BrdU (clone B44; BD Biosciences, 347583) in blocking 
buffer for 1 h. Following three washes in PBS- Tween followed 
by incubation with anti- rat Alexa Fluor 555 and anti- mouse 
Alexa Fluor 488 (Thermo Fisher Scientific). DNA fibres were 
visualised by immunofluorescence microscopy using a Leica 
DM6000B epifluorescence microscope.
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